Skip to main content

As with many other substances, a patient’s use of marijuana, both medically and recreationally, can impact physical therapy outcomes.

We have a lot yet to learn, and many issues are in flux: State laws and regulations around medical and recreational use are changing, making it imperative to understand what is and isn't permitted in your state. Similarly, FDA Controlled Substance Act classifications around the variety of products derived from cannabis and cannabinoids can be complex, with drug classifications ranging from Schedule I to Schedule V. To date, there is not enough data to make recommendations for the clinical use of topical cannabinoids.

Though our understanding is evolving, information is increasingly available as use becomes more and more common. Here are some resources that can help you gain perspective on the issue.

Log in or create a free account to keep reading.

Join APTA to get unlimited access to content.

You Might Also Like...


APTA Contributes to Opioid Playbook for Interdisciplinary Care

Mar 15, 2018

Ending the opioid epidemic will require collaboration among providers and professionals across the continuum of health care settings.


Behind the Numbers: Keeping the Patient at the Center of Pain Management

Feb 25, 2018

  The Centers for Disease Control and Prevention (CDC) reports that over 115 people die from opioid overdose every day in the United States. In 2016 alone,